• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析 tau 在性激素反应性癌症中的作用:从阿尔茨海默病中得到的启示。

Untangling the role of tau in sex hormone responsive cancers: lessons learnt from Alzheimer's disease.

机构信息

Cancer Endocrinology Group, Learning & Research Building, Southmead Hospital, Translational Health Sciences, Bristol Medical School, Bristol BS10 5NB, UK.

Department of Urology, Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB, UK.

出版信息

Clin Sci (Lond). 2024 Nov 6;138(21):1357-1369. doi: 10.1042/CS20230317.

DOI:10.1042/CS20230317
PMID:39469929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11522895/
Abstract

Tubulin associated unit has been extensively studied in neurodegenerative diseases including Alzheimer's disease (AD), whereby its hyperphosphorylation and accumulation contributes to disease pathogenesis. Tau is abundantly expressed in the central nervous system but is also present in non-neuronal tissues and in tumours including sex hormone responsive cancers such as breast and prostate. Curiously, hormonal effects on tau also exist in an AD context from numerous studies on menopause, hormone replacement therapy, and androgen deprivation therapy. Despite sharing some risk factors, most importantly advancing age, there are numerous reports from population studies of, currently poorly explained inverse associations between cancer and Alzheimer's disease. We previously reviewed important components of the phosphoinositide-3-kinase/protein kinase B (PI3K/Akt) signalling pathway and their differential modulation in relation to the two diseases. Similarly, receptor tyrosine kinases, estrogen receptor and androgen receptor have all been implicated in the pathogenesis of both cancer and AD. In this review, we focus on tau and its effects in hormone responsive cancer in terms of development, progression, and treatment and in relation to sex hormones and PI3K/Akt signalling molecules including IRS-1, PTEN, Pin1, and p53.

摘要

微管相关蛋白在神经退行性疾病中被广泛研究,包括阿尔茨海默病(AD),其过度磷酸化和积累有助于疾病的发病机制。Tau 在中枢神经系统中大量表达,但也存在于非神经元组织和肿瘤中,包括性激素反应性癌症,如乳腺癌和前列腺癌。奇怪的是,许多关于绝经、激素替代疗法和雄激素剥夺疗法的 AD 研究也存在激素对 Tau 的影响。尽管存在一些共同的危险因素,最重要的是年龄的增长,但目前有大量来自人群研究的报告表明,癌症和阿尔茨海默病之间存在着许多难以解释的负相关关系。我们之前回顾了磷酸肌醇-3-激酶/蛋白激酶 B(PI3K/Akt)信号通路的重要组成部分及其与两种疾病的差异调节。同样,受体酪氨酸激酶、雌激素受体和雄激素受体都与癌症和 AD 的发病机制有关。在这篇综述中,我们重点关注 Tau 及其在激素反应性癌症中的作用,包括其在癌症发展、进展和治疗中的作用,以及与性激素和 PI3K/Akt 信号分子(包括 IRS-1、PTEN、Pin1 和 p53)的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc9/11522895/6bf615eacdae/cs-138-cs20230317-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc9/11522895/1ffb77c0eb64/cs-138-cs20230317-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc9/11522895/6bf615eacdae/cs-138-cs20230317-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc9/11522895/1ffb77c0eb64/cs-138-cs20230317-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc9/11522895/6bf615eacdae/cs-138-cs20230317-g2.jpg

相似文献

1
Untangling the role of tau in sex hormone responsive cancers: lessons learnt from Alzheimer's disease.解析 tau 在性激素反应性癌症中的作用:从阿尔茨海默病中得到的启示。
Clin Sci (Lond). 2024 Nov 6;138(21):1357-1369. doi: 10.1042/CS20230317.
2
Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K/Akt Pathway Provide Clues?综述:癌症与阿尔茨海默病的相反病理:PI3K/Akt 通路是否提供了线索?
Front Endocrinol (Lausanne). 2020 Jun 23;11:403. doi: 10.3389/fendo.2020.00403. eCollection 2020.
3
Stimulation of ACE2/ANG(1-7)/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway.地昔尼尔通过刺激 ACE2/ANG(1-7)/Mas 轴减轻 D-半乳糖-去卵巢大鼠阿尔茨海默病模型:PI3K/Akt 通路的作用。
Mol Neurobiol. 2018 Oct;55(10):8188-8202. doi: 10.1007/s12035-018-0966-3. Epub 2018 Mar 7.
4
TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro.TREM2通过PI3K/Akt/GSK-3β信号通路在体内和体外抑制tau蛋白过度磷酸化和神经元凋亡。
Mol Neurobiol. 2023 May;60(5):2470-2485. doi: 10.1007/s12035-023-03217-x. Epub 2023 Jan 20.
5
Qingxin Kaiqiao Fang decreases Tau hyperphosphorylation in Alzheimer's disease via the PI3K/Akt/GSK3β pathway in vitro and in vivo.清心开窍方通过PI3K/Akt/GSK3β通路在体外和体内降低阿尔茨海默病中的Tau蛋白过度磷酸化。
J Ethnopharmacol. 2024 Jan 10;318(Pt B):117031. doi: 10.1016/j.jep.2023.117031. Epub 2023 Aug 12.
6
Polyphenols isolated from lychee seed inhibit Alzheimer's disease-associated Tau through improving insulin resistance via the IRS-1/PI3K/Akt/GSK-3β pathway.从荔枝核中分离得到的多酚通过改善胰岛素抵抗,经由 IRS-1/PI3K/Akt/GSK-3β 通路抑制与阿尔茨海默病相关的 Tau。
J Ethnopharmacol. 2020 Apr 6;251:112548. doi: 10.1016/j.jep.2020.112548. Epub 2020 Jan 7.
7
Cryptotanshinone Attenuates Amyloid-β-induced Tau Phosphorylation by Regulating PI3K/Akt/GSK3β Pathway in HT22 Cells.隐丹参酮通过调节 HT22 细胞中的 PI3K/Akt/GSK3β 通路来抑制淀粉样β诱导的 Tau 磷酸化。
Mol Neurobiol. 2022 Jul;59(7):4488-4500. doi: 10.1007/s12035-022-02850-2. Epub 2022 May 16.
8
Naringin Protects against Tau Hyperphosphorylation in A -Injured PC12 Cells through Modulation of ER, PI3K/AKT, and GSK-3 Signaling Pathways.柚皮苷通过调节内质网、PI3K/AKT 和 GSK-3 信号通路来防止 A 损伤的 PC12 细胞中的 Tau 过度磷酸化。
Behav Neurol. 2023 Feb 15;2023:1857330. doi: 10.1155/2023/1857330. eCollection 2023.
9
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.通过共同靶向雷帕霉素哺乳动物靶蛋白、蛋白激酶B或丝裂原活化蛋白激酶激酶克服雌激素受体阳性乳腺癌中因PTEN水平降低导致的内分泌抵抗。
Breast Cancer Res. 2014 Sep 11;16(5):430. doi: 10.1186/s13058-014-0430-x.
10
Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.复智散改善11月龄APP/PS1转基因小鼠海马区β淀粉样蛋白生成及tau蛋白磷酸化:蛋白质免疫印迹研究
Exp Gerontol. 2016 Nov;84:88-95. doi: 10.1016/j.exger.2016.09.003. Epub 2016 Sep 7.

本文引用的文献

1
Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis.前列腺癌雄激素剥夺治疗与神经认知障碍:一项系统评价与荟萃分析
Prostate Cancer Prostatic Dis. 2024 Sep;27(3):507-519. doi: 10.1038/s41391-023-00785-w. Epub 2024 Jan 2.
2
Estrogen Receptor Signaling in Breast Cancer.乳腺癌中的雌激素受体信号传导
Cancers (Basel). 2023 Sep 23;15(19):4689. doi: 10.3390/cancers15194689.
3
Cancer-specific association between Tau (MAPT) and cellular pathways, clinical outcome, and drug response.
tau(MAPT)与细胞通路、临床结局和药物反应的癌症特异性关联。
Sci Data. 2023 Sep 20;10(1):637. doi: 10.1038/s41597-023-02543-y.
4
Estrogen promotes Epithelial ovarian cancer cells proliferation via down-regulating expression and activating phosphorylation of PTEN.雌激素通过下调 PTEN 的表达和激活其磷酸化来促进卵巢上皮癌细胞的增殖。
Arch Biochem Biophys. 2023 Jul 15;743:109662. doi: 10.1016/j.abb.2023.109662. Epub 2023 Jun 3.
5
A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk.多基因panel 研究鉴定出与前列腺癌风险相关的单核苷酸多态性。
Int J Mol Sci. 2023 Apr 20;24(8):7594. doi: 10.3390/ijms24087594.
6
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer.乳腺癌中雌激素受体信号通路的基础研究综述
Int J Mol Sci. 2023 Apr 6;24(7):6834. doi: 10.3390/ijms24076834.
7
Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography.绝经年龄和激素治疗使用与 Tau 和 β-淀粉样蛋白正电子发射断层扫描的关联。
JAMA Neurol. 2023 May 1;80(5):462-473. doi: 10.1001/jamaneurol.2023.0455.
8
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells.有丝分裂时 Tau/MAPT 的磷酸化调节前列腺癌细胞的细胞周期进程。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7689-7701. doi: 10.1007/s00432-023-04721-2. Epub 2023 Mar 31.
9
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment.探讨 AR 与 PI3K/AKT/mTOR 信号通路之间的相互串扰在前列腺癌治疗中的作用。
Int J Mol Sci. 2023 Jan 24;24(3):2289. doi: 10.3390/ijms24032289.
10
Cancer Cells Upregulate Tau to Gain Resistance to DNA Damaging Agents.癌细胞上调tau蛋白以获得对DNA损伤剂的抗性。
Cancers (Basel). 2022 Dec 24;15(1):116. doi: 10.3390/cancers15010116.